Division of Epidemiology Archive — Page 1 of 9

Glowing blue and magenta DNA double helix formed from particles, surrounded by streams of digital numbers and data-like light patterns.
May 29, 2026

AI technique improves cancer gene discovery for breast and prostate cancer

The artificial intelligence model Enformer was retrained with tissue-specific datasets; this “transfer learning” approach outperformed the base model in identifying disease-associated genes.

Medical illustration of a colonoscope inside the bowel, positioned beside a small polyp being removed with a wire loop.
February 27, 2026

Demographic and histologic factors influence risk of colon polyp recurrence

Vanderbilt Health study supports shift toward dynamic surveillance that extends monitoring for patients with specific demographic and histologic risk profiles.

Weekly pill organizer compartments filled with assorted capsules and tablets, with orange prescription bottles in the background.
February 25, 2026

Patients with atrial fibrillation face higher bleeding risks when treated with 2 common medications

While diltiazem remains an effective option for heart rate control in selected patients, bleeding risk posed by anticoagulants should be considered.

Abstract green and blue digital network with glowing grid lines, data points, and layered wave-like forms around a dark central area.
February 6, 2026

New analytical approach identifies novel risk genes for colorectal cancer

The study advances understanding of risk for colon and rectal cancers and points to targets for developing new treatments.

Four co-authors stand side by side against a beige wall: Danxia Yu, Zicheng Wang, Lei Wang, and Jason Samuels, who wears a white medical coat.
January 9, 2026

Weight loss drugs and bariatric surgery improve the body’s fat ‘balance:’ study

The retrospective study analyzed the electronic health records of 1,257 patients ages 18 to 65 who underwent bariatric surgery at Vanderbilt Health from 2017 to 2022, and 1,809 patients treated with the drugs semaglutide or tirzepatide from 2018 to 2023. 

Futuristic medical illustration showing a tablet with glowing DNA strands, three medicine vials, a syringe, a human figure, a DNA icon, and a magnifying glass on a digital blue interface.
December 3, 2025

Large-scale integration of genomics, proteomics and clinical records identifies cancer risk proteins and potential therapeutics

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.